SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics

Low efficacy of treatments and chemoresistance are challenges in addressing refractory hepatocellular carcinoma (HCC). SPINK1, an oncogenic protein, is frequently overexpressed in many HCC cases. However, the impact of SPINK1 on HCC treatment resistance remains poorly understood. Here, we elucidate...

Full description

Bibliographic Details
Main Authors: Chunyuan Yang, Limei Guo, Juan Du, Qiulu Zhang, Lingfu Zhang
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/14/3/265
_version_ 1827306885408096256
author Chunyuan Yang
Limei Guo
Juan Du
Qiulu Zhang
Lingfu Zhang
author_facet Chunyuan Yang
Limei Guo
Juan Du
Qiulu Zhang
Lingfu Zhang
author_sort Chunyuan Yang
collection DOAJ
description Low efficacy of treatments and chemoresistance are challenges in addressing refractory hepatocellular carcinoma (HCC). SPINK1, an oncogenic protein, is frequently overexpressed in many HCC cases. However, the impact of SPINK1 on HCC treatment resistance remains poorly understood. Here, we elucidate the functions of SPINK1 on HCC therapy resistance. Analysis of SPINK1 protein level reveals a correlation between elevated SPINK1 expression and unfavorable prognosis. Furthermore, intercellular variations in SPINK1 expression levels are observed. Subsequent examination of single cell RNA-sequencing data from two HCC cohorts further suggest that <i>SPINK1</i>-high cells exhibit heightened activity in drug metabolic pathways compared to <i>SPINK1</i>-low HCC cells. High <i>SPINK1</i> expression is associated with reduced sensitivities to both chemotherapy drugs and targeted therapies. Moreover, spatial transcriptomics data indicate that elevated <i>SPINK1</i> expression correlates with non-responsive phenotype during treatment with targeted therapy and immune checkpoint inhibitors. This is attributed to increased levels of drug metabolic regulators, especially <i>CES2</i> and <i>CYP3A5</i>, in <i>SPINK1</i>-high cells. Experimental evidence further demonstrates that <i>SPINK1</i> overexpression induces the expression of <i>CES2</i> and <i>CYP3A5</i>, consequently promoting chemoresistance to sorafenib and oxaliplatin. In summary, our study unveils the predictive role of SPINK1 on HCC treatment resistance, identifying it as a potential therapeutic target for refractory HCC.
first_indexed 2024-04-24T18:29:58Z
format Article
id doaj.art-45e37c86b1344592b5c748594e18e21e
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-04-24T18:29:58Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-45e37c86b1344592b5c748594e18e21e2024-03-27T13:27:49ZengMDPI AGBiomolecules2218-273X2024-02-0114326510.3390/biom14030265SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial TranscriptomicsChunyuan Yang0Limei Guo1Juan Du2Qiulu Zhang3Lingfu Zhang4Institute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, ChinaInstitute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, ChinaInstitute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, ChinaInstitute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, ChinaDepartment of General Surgery, Peking University Third Hospital, Beijing 100191, ChinaLow efficacy of treatments and chemoresistance are challenges in addressing refractory hepatocellular carcinoma (HCC). SPINK1, an oncogenic protein, is frequently overexpressed in many HCC cases. However, the impact of SPINK1 on HCC treatment resistance remains poorly understood. Here, we elucidate the functions of SPINK1 on HCC therapy resistance. Analysis of SPINK1 protein level reveals a correlation between elevated SPINK1 expression and unfavorable prognosis. Furthermore, intercellular variations in SPINK1 expression levels are observed. Subsequent examination of single cell RNA-sequencing data from two HCC cohorts further suggest that <i>SPINK1</i>-high cells exhibit heightened activity in drug metabolic pathways compared to <i>SPINK1</i>-low HCC cells. High <i>SPINK1</i> expression is associated with reduced sensitivities to both chemotherapy drugs and targeted therapies. Moreover, spatial transcriptomics data indicate that elevated <i>SPINK1</i> expression correlates with non-responsive phenotype during treatment with targeted therapy and immune checkpoint inhibitors. This is attributed to increased levels of drug metabolic regulators, especially <i>CES2</i> and <i>CYP3A5</i>, in <i>SPINK1</i>-high cells. Experimental evidence further demonstrates that <i>SPINK1</i> overexpression induces the expression of <i>CES2</i> and <i>CYP3A5</i>, consequently promoting chemoresistance to sorafenib and oxaliplatin. In summary, our study unveils the predictive role of SPINK1 on HCC treatment resistance, identifying it as a potential therapeutic target for refractory HCC.https://www.mdpi.com/2218-273X/14/3/265SPINK1hepatocellular carcinomasingle cell RNA sequencingspatial transcriptomicsCES2CYP3A5
spellingShingle Chunyuan Yang
Limei Guo
Juan Du
Qiulu Zhang
Lingfu Zhang
SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics
Biomolecules
SPINK1
hepatocellular carcinoma
single cell RNA sequencing
spatial transcriptomics
CES2
CYP3A5
title SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics
title_full SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics
title_fullStr SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics
title_full_unstemmed SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics
title_short SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics
title_sort spink1 overexpression correlates with hepatocellular carcinoma treatment resistance revealed by single cell rna sequencing and spatial transcriptomics
topic SPINK1
hepatocellular carcinoma
single cell RNA sequencing
spatial transcriptomics
CES2
CYP3A5
url https://www.mdpi.com/2218-273X/14/3/265
work_keys_str_mv AT chunyuanyang spink1overexpressioncorrelateswithhepatocellularcarcinomatreatmentresistancerevealedbysinglecellrnasequencingandspatialtranscriptomics
AT limeiguo spink1overexpressioncorrelateswithhepatocellularcarcinomatreatmentresistancerevealedbysinglecellrnasequencingandspatialtranscriptomics
AT juandu spink1overexpressioncorrelateswithhepatocellularcarcinomatreatmentresistancerevealedbysinglecellrnasequencingandspatialtranscriptomics
AT qiuluzhang spink1overexpressioncorrelateswithhepatocellularcarcinomatreatmentresistancerevealedbysinglecellrnasequencingandspatialtranscriptomics
AT lingfuzhang spink1overexpressioncorrelateswithhepatocellularcarcinomatreatmentresistancerevealedbysinglecellrnasequencingandspatialtranscriptomics